Canadian Sec - Delayed Quote CAD

Cresco Labs Inc. (CL.CN)

0.9400
-0.0600
(-6.00%)
At close: May 21 at 3:59:00 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 175.91M
Earnings --

Q1'24

Q2'24

Q3'24

Q4'24

0
50M
100M
150M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.69
2.51 Average
0.9400 Current
3.13 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1133
Avg. Estimate -0.03-0.03-0.11-0.07
Low Estimate -0.03-0.03-0.15-0.09
High Estimate -0.03-0.03-0.08-0.06
Year Ago EPS 00.020.02-0.11

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 8687
Avg. Estimate 165.48M170.62M694.08M719.19M
Low Estimate 161.5M166.5M675.6M684M
High Estimate 168.5M173M710M744M
Year Ago Sales 184.29M184.36M724.34M694.08M
Sales Growth (year/est) -10.21%-7.45%-4.18%3.62%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.03-0.01-0.01-0.01
EPS Actual 00.02-0.01-0.01
Difference 0.030.03-0-0
Surprise % 118.24%375.71%-42.86%-6.43%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.03-0.03-0.11-0.07
7 Days Ago 00-0.12-0.08
30 Days Ago 00-0.12-0.08
60 Days Ago 00-0.08-0.06
90 Days Ago 00-0.08-0.06

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days 1111
Down Last 30 Days 1111

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CL.CN -714.04%-245.08%-644.23%33.75%
S&P 500 13.32%2.61%7.73%13.77%

Upgrades & Downgrades

Reiterates Needham: Hold 8/12/2024
Initiated Zuanic & Associates: Overweight 6/12/2024
Maintains Wedbush: Outperform to Outperform 5/16/2024
Reiterates Needham: Hold to Hold 5/16/2024
Maintains Roth MKM: Neutral to Neutral 3/14/2024
Maintains Wedbush: Outperform 3/20/2023

Related Tickers